Study shows increased risk for cardiovascular disease in youth with HIV

February 25, 2014, National Institutes of Health

Nearly half of adolescents who have had HIV since birth may be at increased risk for cardiovascular disease—including heart attack and stroke—later in life, according to a National Institutes of Health network study.

The findings are the latest results from the Pediatric HIV/AIDS Cohort Study (PHACS), a multi-site, long-term follow-up study of children and youth who have had HIV since birth, sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and supported by eight other institutes at NIH.

The results are based on clinical assessments of 165 teens age 15 or older with HIV, who were born to mothers with HIV and who have been treated with anti-HIV medications since birth.

The researchers estimated each study participant's overall using a score based on measures of cholesterol levels, blood sugar level, smoking, blood pressure, and weight. The combined score has been shown to predict the presence of buildup and thickening in the major arteries to the heart and abdomen, known to increase the risk for conditions such as heart attack and stroke.

The study results were published online in Circulation.

According to the study authors, previous studies have found that the severity of HIV infection and a history of taking specific HIV drugs are linked to in adults. The current study is the first to evaluate overall risk for cardiovascular disease in teens with HIV infection since birth.

The study's first author was Kunjal Patel, D.Sc., M.P.H., of the Harvard School of Public Health, in Boston. Other authors were from the 14 institutions affiliated with the PHACS Network.

"Our results show that a large proportion of teens who have had HIV their whole lives appear to be at significant risk for cardiovascular disease later in life," said co-author George Siberry, M.D., of NICHD, one of the NIH institutes supporting the study. "These results indicate that individuals who have had HIV since birth should be monitored carefully by their health care providers for signs of cardiovascular disease."

To calculate a participant's cardiovascular disease risk, the researchers used a scoring system called the Pathobiological Determinants of Atherosclerosis in Youth, or PDAY. The PDAY score is calculated on the basis of a person's cholesterol levels, blood sugar levels, weight, and other factors known to influence risk of cardiovascular disease. The score estimates the likelihood that a person has a build-up of artery clogging plaque in the coronary arteries or in the (the main artery in the abdomen). Researchers consider a PDAY score of 1 to indicate an 18 percent or 24 percent greater chance of plaque build-up in the coronary arteries or abdominal aorta respectively, compared to a score of zero, thought to indicate the chances for cardiovascular disease among those of the same age and sex with no known risk factors.

Of participants in this study of adolescents with HIV infection since birth, 48 percent had a score of 1 or higher for the coronary artery measure. For the abdominal aorta measure, 24 percent scored 1 or above. The researchers also evaluated changes in PDAY scores over a four-year time period and did not observe any major trends.

The study authors noted that PDAY scores of 1 or higher were primarily attributable to high . Other risk factors, such as smoking and high blood pressure, that are more common in older adults, were uncommon in these young participants. Participants who were treated with the HIV drug class known as protease inhibitors were more likely to have higher PDAY scores. Teens with a history of AIDS were also more likely to have higher PDAY scores. This study only looked at HIV-specific factors influencing cardiovascular risk in this group. It did not look at other factors such as diet, physical activity, or genetics. The study authors called for more research to understand all the potential factors that could influence cardiovascular risk in this group.

"It's too soon to recommend changing treatment regimens on the basis of our findings," Dr. Patel said. "Until we can learn more, we can best serve adolescents who have HIV by monitoring their risk factors for heart disease carefully and urging them to adopt other measures that have been found to reduce the risk of heart disease in the general population: exercising, maintaining a healthy diet, and not smoking.

Explore further: Plaque composition, immune activation explain cardiovascular risk in HIV-infected women

Related Stories

Plaque composition, immune activation explain cardiovascular risk in HIV-infected women

December 13, 2013
A Massachusetts General Hospital (MGH) research team has discovered a possible mechanism behind the elevated risk of cardiovascular disease in women infected with HIV, a risk even higher than that of HIV-infected men. In ...

Tests to predict heart problems may be more useful predictor of memory loss than dementia tests

April 1, 2013
Risk prediction tools that estimate future risk of heart disease and stroke may be more useful predictors of future decline in cognitive abilities, or memory and thinking, than a dementia risk score, according to a new study ...

Atherosclerosis in HIV patients linked to infection, not treatment

October 30, 2013
HIV infection, not antiretroviral therapy (ART), is associated with risk for atherosclerosis in patients with no history of smoking, particularly those infected for eight years or more. Results of the study led by Moïse ...

HIV causes structural heart disease

December 11, 2013
HIV causes structural heart disease according to research presented at EuroEcho-Imaging 2013 by Dr Nieves Montoro from Madrid, Spain. The findings support the introduction of cardiovascular screening in all HIV patients, ...

Study demonstrates need to change scoring system for heart disease

January 13, 2014
A study led by researchers at the University of California, San Diego School of Medicine shows that one of the most widely used systems for predicting risk of adverse heart events should be re-evaluated. A surprise finding ...

Increased risk of neurological, cognitive deficits in youth with HIV

August 30, 2013
More than 65 percent of HIV-infected youth had mild to moderate impairments in fine-motor skills, memory, and other cognitive skills, although not enough to affect day-to-day functioning for most, according to a National ...

Recommended for you

A nanoparticle inhalant for treating heart disease

January 18, 2018
A team of researchers from Italy and Germany has developed a nanoparticle inhalant for treating people suffering from heart disease. In their paper published in the journal Science Translational Medicine, the group describes ...

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.